Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT07559136

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity

Conditions: Overweight and Obesity

Sex: All

Ages: 12 Years – 18 Years

Healthy volunteers: No

Phase: PHASE1

Enrollment: 48

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.

Location: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei

Summary

The aim of this trial is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS9531 injection compared with placebo in adolescents with obesity

Eligibility Criteria

Inclusion Criteria: 1. Male or female subjects who are aged ≥12 years and \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07559136). StuddyBuddy aggregates publicly available trial information.